Impact of SAfinamide on Depressive Symptoms in Parkinson’s Disease Patients (SADness-PD Study): A Multicenter Retrospective Study

Background: We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Parkinson’s disease (PD). Methods: We retrospectively analyzed the data of patients at 1 and 3 months of follow-up...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Esteban Peña, Carmen Borrué, Marina Mata, Juan Carlos Martínez-Castrillo, Araceli Alonso-Canovas, Juan Luis Chico, Lydia López-Manzanares, Marcos Llanero, Jaime Herreros-Rodríguez, Alberto Esquivel, Teresa Maycas-Cepeda, Cristina Ruíz-Huete
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2021-02-01
Serie:	Brain Sciences
Soggetti:	Parkinson’s disease depression serotonin syndrome antidepressants safinamide motor symptoms
Accesso online:	https://www.mdpi.com/2076-3425/11/2/232
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!